Provided by Tiger Trade Technology Pte. Ltd.

Xenon Pharmaceuticals

59.87
-0.3500-0.58%
Volume:118.34K
Turnover:7.10M
Market Cap:5.79B
PE:-12.72
High:61.16
Open:60.48
Low:59.55
Close:60.22
52wk High:72.66
52wk Low:35.60
Shares:96.64M
Float Shares:95.45M
Volume Ratio:0.40
T/O Rate:0.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7061
EPS(LYR):-4.3646
ROE:-43.62%
ROA:-28.02%
PB:4.66
PE(LYR):-13.72

Loading ...

Xenon Pharmaceuticals Q2 Operating Expenses USD 123.155 Million

THOMSON REUTERS
·
Aug 07

Xenon Pharmaceuticals - Anticipates Sufficient Cash to Fund Operations into 2029

THOMSON REUTERS
·
Aug 07

Xenon Reports Q2 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
Aug 07

Xenon Pharma Grants 32,758 Inducement Stock Options, 19,013 RSUs to New Hires

Reuters
·
Aug 01

Xenon Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 01

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Aug 01

Movement Alert|Xenon Pharmaceuticals Falls 5.07% in Regular Trading, Trading at $67.3

Market Focus
·
Jul 10

Movement Alert|Xenon Pharmaceuticals Rises 7.25% in Regular Trading, Trading at $68.07

Market Focus
·
Jul 09

Xenon Pharmaceuticals Grants 20,200 Inducement Stock Options, 11,850 Rsus to New Hires

Reuters
·
Jul 03

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jul 03

Xenon shareholders approve 2026 equity incentive plan at annual meeting

Reuters
·
Jun 04

BRIEF-Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule

Reuters
·
May 30

Xenon Pharma grants 32,750 inducement stock options priced at $54.79 per share

Reuters
·
May 30

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 30

Xenon Pharmaceuticals Is Maintained at Overweight by JP Morgan

Dow Jones
·
May 27

Xenon Pharmaceuticals price target raised to $82 from $80 at JPMorgan

TIPRANKS
·
May 27

Xenon Pharmaceuticals Signals Strong Momentum In Earnings

TIPRANKS
·
May 20

A Look At Xenon Pharmaceuticals (XENE) Valuation After Phase III Azetukalner Milestones And Extended Cash Runway

Simply Wall St.
·
May 14

Xenon Pharmaceuticals Is Maintained at Overweight by JP Morgan

Dow Jones
·
May 12

Xenon Pharmaceuticals price target raised to $80 from $77 at JPMorgan

TIPRANKS
·
May 12